Pharmacy Automation Market – Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017–2025

coherentmarketinsights

Pharmacy automation is a mechanical process where handling and distribution of medications takes place in hospital pharmacy or at retail pharmacy. It includes any pharmacy task that involves counting of small objects such as tablets or capsules, measuring and mixing of powders and liquids for compounding, tracking and updating customer information in databases such as personally identifiable information (PPI), drug interaction risk detection, medical history and inventory management. The pharmacy automation market is expected to favor the growth owing to features such as system integration, which increases the productivity and time to clinicians for patient care.

Furthermore, demand for pharmaceutical products, technologically advanced robotic equipment and tools to perform operations at faster rate pharmacy automation is required in the near future. Whereas, constant developments in technology favors dispensing of prescription medications safer, more accurate and more efficient. Pharmacy automation has helped to provide improved workflow and efficiency to pharmacist as pharmacy automation can manage over 200-300 medications and patient information in an effective and secure manner. Furthermore, increasing government initiatives to improve healthcare infrastructure in emerging economies such as India and China is in turn expected to fuel growth of the pharmacy automation market.

  • Pharmacy Automation Market Taxonomy

  • By Product Type

  • Automated Medication Dispensing

  • Automated Storage and Retrieval Systems

  • Automated Packaging and Labeling

  • Tabletop Tablet Counter

  • Automated Compounding Devices

  • By End-User

  • Retail Pharmacy

  • Hospital Pharmacy

Increase in need to reduce medication errors fuels the pharmacy automation market

Medication errors such as failure in the drug prescription or dispensing process is lethal to patients, which occurs due to increase in number of customers and work load on pharmacist that encourages the pharmacist to buy pharmacy automation. Whereas pharmacy automation systems in hospital or at retail pharmacy manages, track drug, supplies health information related to patient so that replenishing of only required items is performed. Additionally, pharmacy automation market is expected to gain traction due to its transparent tracking systems as pharmacy automation accurately maintain the record of medications expiry date and physical quantities which helps to reduce the medication error. According to National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) around 0.1 million people die annually due to medical errors in hospital in 2014.

Regional growth engines for pharmacy automation market

Increase in number of drug prescriptions at pharmacies due to growth in aging population in North America and increase in insurance coverage in the U.S. has elevated the burden from healthcare system of the country, which has highlighted that there is need of improvement in management of work, which is possible by using pharmacy automation.

Furthermore, rapid rise in number of patients and demand for quality care is expected to have a positive impact and also increase in technology advancement in healthcare IT infrastructure also boost the pharmacy automation market in Latin America, Middle East, Africa and Asia Pacific.

Key players to support pharmacy automation market

Technological advancement in pharmacy automation systems have improved pharmacy operation which leads to competition in various manufactures to innovate the product. For example Becton Dickinson and Company developed Cato Mediation Workflow software with an optional camera-based visual documentation hardware that provides visual documentation of syringe, vial and IV container information. Key player operating in pharmacy automation market include Baxter International Inc., Cerner Corporation, Becton Dickinson and Company, McKesson Corporation, Swisslog Holdings AG, Capsa Healthcare, ScriptPro LLC, Yuyama Co., Ltd., Omnicell Inc. and Talyst, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email:sales@coherentmarketinsights.com

Medical Specialty Bags Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

coherentmarketinsights

Medical specialty bags are specially designed bag for use in various medical areas such as in the collection and storage of blood samples, urine collection, enteral feeding and sterile packaging. This bags are most probably used in hospitals for the maintenance of sterilized condition of blood sample which helps in control of disease spreading and in leakage of medicines or blood samples. Blood bags are sterile bags and are nontoxic or reduce the toxicity and can store the blood for a relatively long period. Therefore, they are used in blood collection and storage of blood, especially in blood banks.

The anesthesia breathing bags are the breathing bags used with face mask that can be placed over the mouth and nose of the patients and provides oxygen for complete breathing. This bags are squeezed and pushes the oxygen flow in the patient’s lungs. This helps in reducing fatigue of hands and also provides firm grip to the hands and are comfortable in use for the patients. This bags are available in various size and are made up of thin durable designs. The ostomy collection bags are used in collection waste from surgically diverted biological system such as colon, ileum, and bladder as ostomy bags are airtight and watertight.

Medical specialty bags market taxonomy

Medical Specialty Bags Market by Product Type:

  • Anesthesia breathing bags
  • Bile collection bags
  • Blood bags
  • Continuous ambulatory peritoneal dialysis (CAPD) bags
  • Enema bags
  • Enteral feeding bags
  • Intravenous fluid/infusion bags
  • Ostomy collection bags
  • Resuscitation bags
  • Urinary collection bags
  • Others

Medical Specialty Bags Market by Geography:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Rise in the prevalence of high blood pressure and increase in chronic kidney disease globally expected to boost the growth of medical specialty bags market

The rise in global aging population, rise in chronic disease cases, increase in health care expenditure and disposable income are the major factors leading to the growth of the medical specialty bags market. Moreover, rise in blood infusion emergencies and increased use of blood bags further augments market growth.

Geographically North America holds the largest market in the medical specialty bags market. Due to the high prevalence of diseases, increase in obesity population, acceptance in new and innovative products and better infrastructure investments support of health care facilities are the major factors driving the growth of medical specialty bags market in North America.

Centers for Disease Control and Prevention (CDC), in 2017 around 30 million (15%) U.S. adults are estimated to have chronic kidney disease and around 48% of those with severely reduce kidney function, and 96% people are suffering with kidney damage. As there is a strong economic growth in this country, rapid growth of medical infrastructure, rise in disposable income and increase in awareness and demand for healthy life, which has led to increase the demand for medical specialty bags.

Rise in incidence of blood infusion emergencies and introduction of PVC free bags is the major factor that drive the blood bag market. This bags are general used for the blood samples collections or for the storage during the heart surgery period. According to the World Health Organization (WHO), worldwide it was estimated that around 7.5million deaths occurred due to high blood pressure. As per Heart Foundation it was estimated that around 4.6 million (32%) Australians aged 18 years and over had high blood pressure in 2012, and out of this around 23.6% women were more likely to have uncontrolled high blood pressure.

Major Market Players of Medical Specialty Bags Include:

  • Braun Melsungen AG,
  • Baxter International, Inc.
  • Coloplast A/S
  • ConvaTec, Inc.
  • Hollister Incorporated
  • Medline Industries Inc.
  • Nolato AB
  • R. Bard, Inc.
  • Macopharma SA
  • Terumo Corporation
  • Smiths Medical
  • Fresenius SE & Co. KGaA

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email:sales@coherentmarketinsights.com

Nebulizers Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

coherentmarketinsights

Nebulizers are drug delivery devices that are used to administer medicines in the form of a mist inhaled into the lungs. This drug delivery method helps in the administration of drugs such as corticosteroids, bronchodilators and anti-inflammatory medications. Nebulizers are mainly used for patients suffering from asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and other respiratory diseases or disorders. It is much comfortable to use than other forms of ingested medicines, as it targets the respiratory area directly, thus reducing side effects and harm to other body organs and cells. Nebulizers are especially used for delivery of drug to breathing passages, reduce bulging of mucous membrane, to reduce irritation caused by pollutants and activate and thin out discharge. These devices are specially developed for adults and children who are not able to handle inhalers.

The use of nebulizer depends on the illness for which it is designed to treat. Various considerations to be taken care of while using a nebulizer are as follows:

  • The appropriate method of using the nebulizer

  • Ways to keep the nebulizer clean for maximum safety and effectiveness

Nebulizers Market taxonomy:

On the basis of product type, the nebulizers market is classified into:

  • Ultrasonic

  • Pneumatic

  • Mesh

Ultrasonic nebulizers include portable and standalone nebulizers.

Pneumatic nebulizers are further classified into:

  • Breath Actuated nebulizers

  • Vented nebulizers

Also, mesh nebulizers are also further classified into:

  • Static type nebulizers

  • Vibrating type nebulizers

Pneumatic nebulizers hold the major share in nebulizers market due to their ease of handling, efficient design and low cost.

On the basis of end user, the nebulizers market is classified into:

  • Hospitals

  • Clinics

  • Ambulatory Surgical Centers

  • Home Care Settings

Product innovation driving the preference for nebulizers in treating respiratory conditions

The advanced nebulizers that features aerosol drug delivery technology with minimal drug wastage is expected to drive the nebulizers market growth. Patients play a vigorous role in supervising their diseases by choosing for devices that assist them in diagnosis and treatment at the comfort of their own homes. This shift in patient preferences will strengthen the global nebulizer market growth scenario in the near future. Also the rise in respiratory cases form a major factor. According to World Health Organization (WHO), around 15.7 million people were reported with Chronic Obstructive Pulmonary Disease (COPD) in the U.S. in 2016 which showed a significant increase of 6.4% from 2015.

Nebulizers are also for a variety of diagnostic procedures among which the principal one is in diagnosis of lung function and bronchial activities. This has also added to the rise in demand for nebulizers in the market by the professionals for clinical use and monitoring of various associated respiratory disorders.

Medical reimbursement supporting the North America nebulizer market growth

There are guidelines laid for nebulizers which facilitates its proper usage. The Centers for Medicare & Medicaid Services, and United HealthCare Services, Inc. have defined guidelines for the proper usage of nebulizers in different respiratory issues. In addition to that there are various reimbursement policies that fuel the growth of the market, for instance, policies by Medicaid & Healthcare Partnership in 2012 helped in the easy purchase of nebulizers. Under Hawaii Medical Service Association, in 2014, several cover plans were made for the easy purchases of small volume and large volume nebulizers.

Also, there exists a rental market for nebulizers that assists the usage of these devices in home care settings.

Since nebulization is a spraying technique, therefore the dispersion and wastage of the drug during delivery to the respiratory tract is one of the major restraint for the growth of nebulizers market. Moreover, low consumer switching cost and availability of alternative therapies increases the threat of substitute products.

By geography, North America holds the major share in the global nebulizers market because of the availability of reimbursement and increasing incidence of respiratory diseases.

Key players in the global nebulizers market are GE Healthcare Ltd, Agilent Technologies, GF Health Products, Philips Healthcare CareFusion Corporation, PARI Respiratory Equipment, Covidien plc and Omron Healthcare Co. The players are undertaking various clinical trials and development activities in an endeavor to improve therapeutic effect of the drug. Theravance Biopharma and Mylan announced the initiation of phase 3 studies of revefenacin at the American Thoracic Society (ATS) International Conference in 2017. Revefenacin is a once-daily long acting muscarinic antagonist (LAMA) nebulized therapy. Development of such drugs intended to be delivered via nebulization will also support propelling the growth for nebulizers market. Also Vectura received FDA approval to start testing a smart technology of nebulizers to improve asthma therapies in children.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Medical Sensors Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

coherentmarketinsights

Medical sensors that measure the physical functions of the body and convert it into an electrical or optical signal. These devices play a major role in the monitoring of chronic diseases such as cancer, cardiovascular and respiratory diseases to measure the physical function and convert it into the electrical signal. The market is majorly directed by the increased demand for medical sensors in diagnostic and therapeutic segments. The medical sensor monitor adds value to the healthcare professional to alert critical deviations, which are recorded in vital signs. This ultimately improves the quality of care given to the patient by avoiding undesirable complications. Moreover, the demand for medical sensors is raised because of its wide range of applications such as monitoring of temperature, pressure, vibration, inclusive of various diagnostic parameters and analysis. As increase in chronic disorders and geriatric population globally has continuously raised the demand for these equipment. Furthermore, chronically ill patients and geriatric population are the target area for sensor-based devices, for instance as per National Institute of Aging, there are around 617 million people above the age of 65 years in 2016 and it will cross 1.6 billion by 2050.

Medical sensors market taxonomy:
By Product Type
Pressure
Temperature
Image
Accelerometers
Biosensors
Flow
Superconducting Quantum
By Application
Surgical
Diagnostic
Therapeutic
Monitoring
By End User
Hospitals
Clinics
Ambulatory Surgical Centers
Others (Nursing Homes, Home Healthcare Facilities)
By Sensors Placement Type
Strip Sensors
Wearable Sensors
Ingestible Sensors
Implantable Sensors
Invasive/ Non-Invasive Sensors
Improved technology and accuracy fuels the growth of medical sensors market
Medical sensors have become a universal segment of the technologically advanced and digital medical devices. There is a significant increase in the development of implantable and wearable medical devices, which facilitate the awareness about medical devices this leads to the increased use of sensors. It is expected that rise in geriatric population, increase in chronic diseases such as chronic obstructive pulmonary disease (COPD), cardiovascular disease, kidney disease and respiratory disease and rise in intensive care for critical patients are the responsible factors supports the growth of medical sensors market. As per Centers for Disease Control and Prevention, there are around 15.7 million people in the U.S. diagnosed with COPD in 2014. Furthermore, there is a wide range of benefits of the use of medical sensors in medical devices, which increased the accuracy in disease management through notifications alerts, and real time patient data communication. Which expected to support the growth of medical sensors market.

Developed regions are major growth engines for medical sensors market
Medical sensors market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa. North America is the leading region due to the annual increase in minimally invasive surgeries performed and availability of healthcare reimbursement policy. However, market across Asia Pacific is expected to expand at a higher rate due to, increase in diabetic population, respiratory diseases cases, cardiovascular disease and raised investment in healthcare sector in emerging countries such as India and China expected to support the growth of medical sensors market.
Key players of the medical sensors market
There are various players present across the globe and running into the competition. The rise in awareness about devices and increase in per capita income of individuals expected to create more opportunities for industry players in global medical sensors market. Some key players are Analog Devices Inc., Broadcom Limited, Danaher, LORD Corporation, Honeywell International Inc., OmniVision Technologies Inc., and GE Measurement & Control.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
E-mail:sales@coherentmarketinsights.com

Guidewires Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

coherentmarketinsights

Guidewires are flexible and thin tubes that guide a catheter for placement in the diseased organ. Guidewires are used to open the target vessels, cross lesions and provide definitive interventional therapy to patients. Guidewires are the crucial components of vascular intervention with indispensable uses in the field of minimally invasive surgeries due to its capacity of rendering precise and effective results. Guidewires are of several types as various clinical presentations need different device features. An appropriate guidewire for a particular condition can improve device delivery, enhance crossing success, restrict expenses and limit the risk of vascular injury. Guidewires are mainly manufactured from stainless steel with an elastic coil tip to prevent blood vessel from damage. The guidewires are reusable products in nature with low cost stainless steel mainly used as a raw material by manufacturers. A robust range of wire configurations and tip shapes makes it possible for healthcare professionals in choosing the right tool for surgical procedures. Biomechanical properties of the guidewires in the medical device industry contributes to its rapid growth.

Extensive use of guidewires in surgical interventions is expected to fuel the growth of guidewires market

According to the Journal of American College of Cardiology, an estimated 422.7 million prevalent cases of cardiovascular diseases were recorded globally in 2015, with 8.9 million deaths observed due to Ischemic Heart Disease (IHD). The higher occurrence of cardiovascular diseases is attributed to the shift in lifestyle habits including dietary irregularities and smoking which results in growing incidences of obesity, thus resulting in the global guidewires market demand. Also, the demand for guidewires is increasing by the rise in patient awareness about the advantages of minimally invasive procedures like decreased traumatic surgical experience, faster recovery, fewer post-surgery complications, reduced incision wounds and higher patient satisfaction. Additionally, growing acceptance of guidewires among medical practitioners, rising research and development investments and surging number of market entrants are the factors propelling guidewires market. Growing use of guidewires for diagnostic and interventional purposes of cardiological diseases is expected to stimulate guidewires market over the forecast period.

Coronary guidewires are largely used guidewires owing to the high volumes of minimally invasive coronary procedures

The global guidewires market is segmented on the basis of product type, application, end user and geography.

On the basis of product type, the global guidewires market is segmented into:

  • Stainless Steel Guidewires

  • Nitinol Guidewires

  • Hybrid Guidewires

On the basis of application, the global guidewires market is segmented into

  • Interventional cardiology

  • Infusion therapy

  • Vascular access

  • Interventional neuroradiology

  • Endourology

  • Gastroenterology

On the basis of end user, the global guidewires market is segmented into:

  • Hospitals

  • Ambulatory Surgical Centers

  • Others

The rise of peripheral vascular diseases fuels the guidewires market in Asia Pacific

Regional segmentation of the global guidewires market by Coherent Market Insights comprises North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. According to Centre for Disease Control and Prevention in 2016, approximately 8.5 million people in the U.S. have peripheral artery disease and is expected to reach 19 million by 2050. Thus, North America holds a dominant position in the global guidewires market. The major driving factors for the growth of the guidewires market in North America, include rise in lifestyle diseases such as heart attack, strokes, myocardial infarction, ischemic stroke, atherosclerosis and neuro vascular diseases. Asia Pacific market is developing at a rapid rate owing to economic development, improving healthcare amenities and government initiatives in the emerging economies. Also, a large group of patients suffering from peripheral vascular diseases leads to an increase in the endovascular procedures in densely populated countries of India and China.

Rapid technological advancements like navigation with a magnetic guidewire is expected to created immense growth opportunities for industry participants

Key players operating the guidewires market are Boston Scientific Corporation, ASAHI INTECC Inc., Cordis Corporation and C.R. Bard. The launch of Glidewire product by Terumo is rapidly gaining popularity in the global market owing to its higher efficiency in vascular access and coronary intervention procedures.  Other leading vendors have adopted technological innovation and advancements for manufacturing novel guidewires in terms of flexibility, construction and tip retention are Terumo Corporation, Medtronic Inc., Abbott Laboratories, Covidienplc, Braun Melsungen and Cook Medical.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Ophthalmic Devices Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

coherentmarketinsights

Ophthalmology refers to a branch of medical sciences that deals with the structural and functional defects of the eye. Ophthalmic devices are medical devices used in the treatment and identification of certain ocular deformities and deficiencies of the eyes. The global ophthalmic devices market is driven by eye disorders such as glaucoma, diabetic retinopathy, macular degeneration, and cataract and vision care devices. Ophthalmic devices are also used in various surgical processes such as ultrasound phacoemulsification for faster recovery rates and improved safety. A wide range of ophthalmic devices are available in the market from high complexity devices such as phoropters , ophthalmoscopes, retinoscopes and scanning laser polarimetry devices to low end products such as contact lenses, spectacles and lens cleaning and disinfecting solutions, Thus, the demand for ophthalmic devices is anticipated to be increasing significantly over the forecast period.

Increasing prevalence of eye disorder is projected to fuel growth of the global ophthalmic devices market

According to the International Journal of Advanced Medical and Health Research 2015, cataract has been reported to be the major cause of blindness, affecting 17-18 million people worldwide, accounting for 39% of such cases. Following cataract, glaucoma is seen to be the second major reason causing blindness among people. According to the Glaucoma Research Organization, over 120,000 people are blind due to glaucoma accounting up to 9-12% of total blind cases. These massive numbers are basically the output of eye disorders prevalence in the geriatric population and changing food habits leading to nutritional deficits in the younger population. The ophthalmic devices can be used in order to treat cataract, glaucoma and several other eye disorders that could propel the global ophthalmic devices market.

The vision care devices segment dominating the global ophthalmic devices market in terms of over the counters sales

The global ophthalmic devices market is segmented on the basis of product type, disorder, and geographical region.

On the basis of product type, the global ophthalmic devices market is segmented as

  • Diagnostic and Monitoring Devices

  • Surgical Devices

  • Vision Care Devices

Vision care devices witnesses maximum sale over the counter and therefore accounts for the largest share. Furthermore there is a rapid rise in number of people affected with eye disorders and increasing awareness among the populace about eye health and safety augments growth of the segment. According to The Vision Council, over 87% of people in the U.S. are reported to be using digital devices for over 2 hours per day, thereby developing eye strain, dry eyes, blurred vision, etc. These small eye related troubles can be sorted with the use of vision care devices in turn potentiating the global ophthalmic devices market. Moreover, rapid growth in the eye diseases such as cataract and glaucoma are resulting in potential growth of the surgical devices segment that would be required in the treatment of these disorders.

On the basis of disorders, the global ophthalmic devices market is segmented as

  • Cataract Surgery Devices

  • Refractive Surgery Devices

  • Vision Care

  • Ophthalmic Diagnostic Devices

  • Vitreo Retinal Surgery Devices

  • Glaucoma Surgery Devices

Emerging economies of Asia Pacific to boost global ophthalmic devices market growth in the forecast period

Based on regional segmentation, the global ophthalmic devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa. The North America is accounted to capture highest share in the global ophthalmic devices market owing to innovation and focus on diagnostic devices and surgery applications as well as higher market penetration levels. The emerging economies such as China, India, Japan and Brazil are estimated to gain an early momentum in the market as a result of massive investments by manufacturers.

Governments in developing countries focusing towards eye safety and vision care thereby mushrooming the global ophthalmic devices market

The annual rise in the prevalence of eye disorders such as cataract, glaucoma and macular degeneration are the major drivers of the global ophthalmic devices market. Several other factors that are responsible to bolster the growth of ophthalmic devices market includes advent of technologically advanced minimally invasive surgery, rise in geriatric population and demand for surgical and diagnostic instruments. The growing occurrence of eye disorders in children will also add up to fuel the market growth. The governments in developing countries supporting to establish sophisticated healthcare infrastructure and eye care centers will in turn favor growth of the global ophthalmic devices market. However, the inadequate awareness among the developing nations regarding vision care and treatments related to eye disorders can inhibit the market growth.

The global ophthalmic market is very vast, rapidly growing as well as highly competitive. Some of the major players operating global ophthalmic market are Johnson and Johnson, Novartis AG, Bausch & Lomb Inc., Essilor International, Abbott Laboratories Inc., VisionCare Inc., Hoya Corporation, Canon Inc., Carl Zeiss AG, Topcon Corporation, Nidek Co Ltd., CooperVision AG and Alcon Inc. The players are sustaining their prime position in the global ophthalmic devices market due to consistency in launching of new ophthalmic devices and eye care products. Alongside, several other new entrants may also create growth opportunities and enhance the growth of the global ophthalmic devices market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Craniomaxillofacial Implants Market to Surpass US$ 3,257.1 Million Threshold by 2025

coherentmarketinsights

The Global Craniomaxillofacial Implants Market was valued at US$ 1,907.9 million in 2016 and is projected to exhibit a CAGR of 6.2% over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights. Increase in demand for reconstruction surgeries and technological advancement, in turn is projected to support growth of the craniomaxillofacial implants market over the forecast period.

Manufacturers are focusing on innovation to tap into emerging markets. For instance, Depuy Synthes launched TRUMATCH Titanium 3D-printed implants in September 2017. OssDsign AB, a Swedish designer, manufacturer, and distributor of next generation craniomaxillofacial implants received FDA clearance for marketing and sales of OSSDSIGN Cranial PSI in the U.S. in January 2017. Efforts are in line to make the craniomaxillofacial implants more biocompatible and resistant to corrosion.

Furthermore, increasing adoption of the concept laser 3D printing technology is also improving the position of manufacturers in the craniomaxillofacial surgery field. The Karl Leibinger Medizitechnik, of the KLS Martin Group is manufacturing craniomaxillofacial implants using Concept Laser M2 cusing machine since 2013.

Manufacturers are also collaborating to strengthen their product portfolio related to craniomaxillofacial implants. Materialise NV, headquartered in Belgium, announced a collaboration with DePuy Synthes, a subsidiary of Johnson & Johnson in July 2016. In this collaboration, Materialise NV is manufacturing patient specific craniomaxillofacial implants utilizing its 3D planning and printing expertise, which would be offered through DePuy Synthes TRUMATCH CMF Solutions in Australia and Europe, excluding France.

Furthermore, factors such as rise in demand for customized craniomaxillofacial implants (for effective results of the treatment), increase in number of road accident cases, and growing geriatric populace are fueling growth of craniomaxillofacial implants market. Usage of bone graft substitutes is increasing in surgeries related to spinal injuries. A number of bone graft substitutes from Stryker Corporation, Synthes, Zimmer Biotech, and Regeneration Technologies are being marketed. Besides, reduced hospitalization time and non-disruptive procedures to fix these craniomaxillofacial implants, which are convenient for both, surgeons and patients, boosts growth of the craniomaxillofacial implant market.

Nevertheless, high costs associated with craniomaxillofacial surgeries, lack of skilled surgeons to carry out the surgery, and inadequate reimbursement is expected to act as a restraint for growth of the craniomaxillofacial implants market.

Key takeaways of the market:

  • The global craniomaxillofacial implants market is expected to exhibit a CAGR of 2% over the forecast period (2017–2025), owing to the rise in the aging population. The Asia Pacific region in the global craniomaxillofacial implants market is expected to exhibit a high growth rate, in terms of value, over the forecast period.
  • Among Material type, Metal segment is expected to exhibit a significant CAGR of 0%.
  • The global craniomaxillofacial implants market is characterized by market expansion in Asia Pacific, North America, and Europe, which is expected to generate higher market revenue due to increase in prevalence of disabilities.

About Coherent Market Insights:

AnchorCoherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

AnchorContact Us:

AnchorMr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email:sales@coherentmarketinsights.com

Solid Tumors Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

coherentmarketinsights

A solid tumor is an abnormal mass or lump of tissues without liquid or cysts. It is not necessary that tumor should always be cancerous. On the basis tumor nature, it can be classified as the malignant tumor (cancerous) and the benign tumor (non-cancerous). Based on the cell type, tumors can be classified as carcinomas, sarcomas, and lymphomas. The Solid tumors might occur in several places such as muscle, bone, and organs. Treatments for solid tumors include prevention of tumor and combination of surgery, chemotherapy, and radiation therapy. However, new forms of treatment are emerging in the market.

Emerging trend of Biosimilars therapy is expected to propel the growth of solid tumors treatment market

According to data published in International Journal of Pharma Sciences and Research (IJPSR) in 2011, there were around 9 million deaths due to cancer. In 2015, 11.4 million people are expected to die in 2030, among this prevalence of cancer maximum is due to solid tumors. Growing prevalence of solid tumors is the major driving factor for the growth of solid tumors treatment market. Additionally, some other factors fuelling the growth of solid tumors treatment market include unmet demand for cancer treatment and rising investment in the research and development of cancer drugs.  However, increase in the volume of generic therapeutic products, the high cost of cancer therapy, and growing drug patent cliff are some of the restraints that might hinder the growth of solid tumors treatment market.

Moreover, the emerging trend of biosimilars is contributing to the growth of solid tumors treatment market due to their low cost and their similarity to originator compound. For instance, some of the biologics available for solid tumors treatment includes Herceptin, MabThera, Avastin, and Erbitux. The advantages of this biosimilars to overcome the limitations of generic drugs in the treatments is expected to propel the growth of solid tumors treatments market.

Chemotherapy segment holds the maximum share in solid tumor treatment market due to its efficacy by combining with some other therapies to treat solid tumors.

The global solid tumors treatment market is segmented by therapy, by application, by the end user, and by region.

On the basis of therapy, solid tumors treatment market is segmented into

  • Radiotherapy

  • Chemotherapy

  • Immunotherapy

  • Hormone therapy

  • Targeted therapy

On the basis of application, solid tumors treatment market is segmented into

  • Lung cancer

  • Breast cancer

  • Prostate cancer

  • Cervical cancer

  • Colorectal cancer

  • others

On the basis of end users, solid tumors treatment market is segmented into

  • Hospitals

  • Cancer treatment centers

Rising incidences of solid tumor cases in North America is the factor contributing to the growth of solid tumor treatment market

Regional segmentation of Solid Tumors Treatment market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Africa, and the Middle East. North America dominates in the solid tumors treatment market due to the presence of well-established healthcare infrastructure, and rise in the number of solid tumor cases. For instance, According to the data provided by Centers for Disease Control and Prevention (CDC) in 2013 around 230,815 females and 2109 men in the U.S. were diagnosed with breast cancer. Asia Pacific is expected to grow in the solid tumors market due to the increase in healthcare expenditure, rising patient population, medical tourism, and increasing affordability of people in this region.

Advanced drug therapy is expected to help the industry players to sustain in the solid tumors treatment market

Key industry players operating solid tumors treatment market include Abbott Laboratories Inc., Biogen Idec Incorporated, AstraZeneca Plc., Johnson & Johnson Company, Amgen Inc., Bristol Myers Squibb Company, GlaxoSmithKline Plc., Sanofi, and Baxter International Incorporated. Advancements in the cancer therapy such as nanomedicines used for the treatment of cancer might help the industry players to provide effective patient care in the solid tumors treatment. Whereas, stringent regulatory policies for drug manufacturing may restrain the growth of the market. For instance, by regulations provided by the Indian government in late 2012, there are cap prices of 348 drugs on Essential Drug List (EDL), and drug manufacturers need to keep the cost of their drugs below the ceiling price.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email:sales@coherentmarketinsights.com

Biopreservation Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

coherentmarketinsights

Biopreservation is the technique used to increase shelf life of product, and to ensure the stability, purity of bio specimens. Bio-preservation is used for the storage of cells, tissues, organs and its recent trend includes its use in food safety. The equipment such as refrigerators, liquid nitrogen and consumables, and media and laboratory information management systems are used for bio preservation. Biobanking is a type of biopreservation that is widely used in medical research such as genomics research and for personalized medicine. Numerous type of bio specimen like saliva, plasma, and purified DNA can be maintained through biopreservation technique and maintain safe from contaminants. Some samples can be stored for longer time with the help of biopreservation so that it can be used for longer research studies.

Increase in government initiatives to boost the research and development is driving the growth of biopreservation market

Increase in number of human sperm and egg banks, and rising demand for preservation of new born stem cells, and adoption of in- house sample storage in hospitals are some of the major factors driving the growth of biopreservation market. Government initiatives in the form of grants, funds, and contract or other type of funding will boost the research and development activities for various companies and research organizations is expected to boost the market. For Instance, according to UK government policy, 2015 explains that there is an expected investment of £5 billion in health and research development by 2020 and additionally Welcome Trust (WT) UK is going to provide funds around £13.9 billion in healthcare research.

Increase in healthcare expenditure globally, investment in bio-banks and personalized medicines, are also propelling the biopreservation market growth. The rising population with lifestyle related diseases, cardiovascular diseases, cancer and hypertension are other factors that are driving the growth of biopreservation market. According to World Health Organization (WHO), in 2015, cardiovascular diseases caused 31% of all diseases and 8.8 million people died due to cancer. However, there are certain restraints effecting the market which includes chances of tissue injury during the preservation, high cost of instruments and their maintenance. The technological breakthroughs and regenerative drugs along with the applications of biobanking for cell, tissue, and organ is expected to create numerous opportunities in the biopreservation market.

Bio-banking segment dominates the biopreservation market due its extensive application in numerous areas

The global biopreservation market is segmented by application, by product type, by bio–specimens, by end user and by region.

On the basis of application, the market is segmented into

  • Bio banking

  • Human eggs

  • Human sperms

  • Veterinary IVF

  • Regenerative medicine

  • Cell therapy

  • Gene therapy

  • Drug discovery

On the basis of product type, the market is segmented into

  • Vials

  • Straws

  • Bags

  • Microtiter plates

  • Equipment

  • Freezers

  • Refrigerators

  • Consumables

  • Others

On the basis of bio–specimens, the market is segmented into

  • Tissue samples

  • Stem cells

  • Organs

  • Others

On the basis of end users, the market is segmented into

  • Bio banks

  • Hospitals

  • Research organizations

  • Others

Biopreservation market is expected to show a sustainable growth in Asia Pacific due to the increase in awareness about preservation of umbilical cord cells

Regional segmentation of global biopreservation market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Middle East and Africa. North America dominates the biopreservation market owing to the factors such as development of novel drugs, increasing demand for diagnosis of chronic diseases, therapies in healthcare sector, and regulations by government to support ethical usage of biological samples. Biopreservation market is driven in the Asia Pacific region due to some factors such as rising population, rise in investments in healthcare research, and growing awareness about preservation of umbilical cord cells. The statistics published in New England Journal of Medicines informed that in 2012, Japan and China had increased their total medical research spending by U.S. $9.0 billion and U.S. $6.4 billion respectively and contributed as 13.8% and 3.1% of world’s total medical research expenditure.

Broad product portfolio of major industries helping them to lead in the biopreservation market

Key players operating the market are Biolife solutions, THERMO- FISHER SCIENTIFIC, BioCision LLC, Simport scientific, Cesca Therapeutics, Atlanta biologics, Lifeline scientific, LabVantage solutions, Hamilton Company, Core dynamics ltd., and others. The major industry players are leading in the biopreservation market due to their broad product portfolio particularly related to media, freezers, refrigerators, consumables and their wide regional presence.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email:sales@coherentmarketinsights.com

Advanced Wound Care Management Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

coherentmarketinsights

Wound is defined as an injury to a tissue, wherein the skin is either cut or torn, thus affecting the dermis of the skin. Wounds are of two types, namely acute and chronic wounds. Acute wounds take approximately eight weeks, following normal stages of wound healing. Whereas, chronic wounds do not follow the normal stages of healing and take longer time to heal. The factors that give rise to chronic wounds include age, diabetes, cancer, obesity, poor nutrition, and infection.

The wound care market is segmented into traditional wound care and advanced wound care products. Health care professionals largely use traditional wound care products under dry environment to protect the wound from external factors. The main focus of these products is to treat the non-severe wounds from bleeding, inhibit infection, and dry the wound. Whereas, Advanced wound care products are used by clinicians to provide a therapeutic effect that supports wound healing. Advanced wound care is based on the theory of moist microenvironment that stimulates the natural healing process without blocking the wound and it includes film and foam dressings, hydrogels, alginates, and hydrocolloids. Besides maintaining a hydrated environment, which is more conducive for wound healing, advanced wound care products keep the temperature consistent, allow flow of oxygen, remove dead tissue, protect the site from exogenous infection, and ease the pain associated with dressing changes.

Alarming growth of diabetic population augments the advanced wound care management market growth

The major factors driving the advanced wound care management market includes the growing incidence of diabetes among the populace According to World Health Organization, in 2014, around 8.5% of the adult population aged 18 years and above had diabetes, while in 2015, 1.6 million deaths occurred due to diabetes. The other factors influencing the advanced wound care management segment growth include the growing geriatric population and rising incidences of chronic wounds. Advanced wound care is also used for different types of ulcers such as pressure ulcers, diabetic ulcers, and chronic ulcers. However, high costs associated with such treatments, one of the factors expected to deter the advanced wound care management market growth.

Negative pressure wound therapy is identified as the most promising technology for advanced wound care

The advanced wound care management market is segmented on the basis of product type, application, end-user, and geographical regions.

On the basis of product type, advanced wound care management market is categorized into moist wound dressings, active wound care and therapy devices. Moist wound dressings is further segmented into foam, films, hydrocolloids, collagen, and alginates. Therapy devices are further segmented into negative pressure wound therapy and pressure relief devices. Active wound care is segmented into skin substitutes and growth factors. 

On the basis of application, advanced wound care management market is categorized into different segments such as skin ulcers, surgical wounds, burn wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers and arterial ulcers. Among all these surgical wounds and skin ulcers are leading the global market.

On the basis of end users, advanced wound care management market is categorized into hospitals, clinics, ambulatory surgical centers and others.

Increasing prevalence of chronic wounds in U.S. to boost the advanced wound care market in North America

On the basis of regional segmentation, advanced wound care management market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America has more significance with all the latest technologies such as negative pressure wound therapy, which is more efficient for treating illnesses. North America is the leading market with the 45% market share, followed by Europe and Asia. Advanced wound care market is expanding steadily and has created ample opportunities for the launch of new products. In terms of imminent growth potential, the emerging economies of Asia Pacific are expected to boost the global advanced wound care management market due to growing population of chronic wound and diabetic patients in the region. The region is expected to witness the fastest growth for the advanced wound care management market in the near future.

Emerging players participating in merger and acquisition and strategic expansion of product portfolio

Key players in the global advanced wound care management market are Johnson & Johnson (J&J), Hill-Rom, KCI, 3M company, Baxter International, Acelity, Coloplast, Integra Lifesciences, Kinetic Concepts, Covidien, Smith & Nephew, Leap Therapeutics, Hematris wound care, Alliqua Bio Medical, Layer Bio, and Triage Meditech.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email:sales@coherentmarketinsights.com